Shan Jiang

Dr. Shan Jiang is a researcher affiliated with the Department of Orthopaedics at the Universitätsklinikum Eppendorf (UKE), Hamburg. Their work focuses on molecular mechanisms underlying bone regeneration, osteoarthritis progression, and musculoskeletal disorders. Key research areas include the role of calcitonin family peptides, β2-adrenergic signaling, and chemokine pathways in bone health. Jiang's studies utilize mouse models to investigate therapeutic targets for post-traumatic osteoarthritis and fracture healing, with a particular interest in drug interventions like tranexamic acid and reboxetine.

Recent research highlights include discovering Cxcl9's role in post-traumatic osteoarthritis attenuation and the dual pro-inflammatory/bone-protective function of calcitonin gene-related peptide alpha. Their work bridges basic science and clinical applications, aiming to improve bone healing outcomes and combat degenerative musculoskeletal diseases.